Barely Significant
← all excerpts

Xinnaoxin tablets ameliorate high-altitude polycythemia-associated cardiac injury by regulating the NF-κB, MAPK, and PI3K/AKT signaling pathways.

Front Pharmacol · 2026 · PMC13253415 · PMID 42292821

2
hedged sentences
closest p
boldest claim

The sentences

a decreasing trendno p-value reported
Although cardiac SOD activity showed a decreasing trend under HH and an increasing trend with low-dose XNX, these changes were not statistically significant ( Figure 6G ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.